Literature DB >> 11042686

Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1.

K M Hannan1, R D Hannan, S D Smith, L S Jefferson, M Lun, L I Rothblum.   

Abstract

We have previously demonstrated that the protein encoded by the retinoblastoma susceptibility gene (Rb) functions as a regulator of transcription by RNA polymerase I (rDNA transcription) by inhibiting UBF-mediated transcription. In the present study, we have examined the mechanism by which Rb represses UBF-dependent rDNA transcription and determined if other Rb-like proteins have similar effects. We demonstrate that authentic or recombinant UBF and Rb interact directly and this requires a functional A/B pocket. DNase footprinting and band-shift assays demonstrated that the interaction between Rb and UBF does not inhibit the binding of UBF to DNA. However, the formation of an UBF/Rb complex does block the interaction of UBF with SL-1, as indicated by using the 48 kDa subunit as a marker for SL-1. Additional evidence is presented that another pocket protein, p130 but not p107, can be found in a complex with UBF. Interestingly, the cellular content of p130 inversely correlated with the rate of rDNA transcription in two physiological systems, and overexpression of p130 inhibited rDNA transcription. These results suggest that p130 may regulate rDNA transcription in a similar manner to Rb.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042686     DOI: 10.1038/sj.onc.1203875

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Overlapping functions of the pRb family in the regulation of rRNA synthesis.

Authors:  S Ciarmatori; P H Scott; J E Sutcliffe; A McLees; H M Alzuherri; J H Dannenberg; H te Riele; I Grummt; R Voit; R J White
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  MDMX regulation of p53 response to ribosomal stress.

Authors:  Daniele M Gilkes; Lihong Chen; Jiandong Chen
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

3.  UBF activates RNA polymerase I transcription by stimulating promoter escape.

Authors:  Kostya I Panov; J Karsten Friedrich; Jackie Russell; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

Review 4.  Structure and epigenetics of nucleoli in comparison with non-nucleolar compartments.

Authors:  Eva Bártová; Andrea Harnicarová Horáková; Radka Uhlírová; Ivan Raska; Gabriela Galiová; Darya Orlova; Stanislav Kozubek
Journal:  J Histochem Cytochem       Date:  2009-12-21       Impact factor: 2.479

5.  Characterization of the interactions of mammalian RNA polymerase I associated proteins PAF53 and PAF49.

Authors:  Yvonne Penrod; Katrina Rothblum; Lawrence I Rothblum
Journal:  Biochemistry       Date:  2012-08-08       Impact factor: 3.162

Review 6.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12

Review 7.  Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes.

Authors:  Sarah J Goodfellow; Joost C B M Zomerdijk
Journal:  Subcell Biochem       Date:  2013

Review 8.  Nucleolus, ribosomes, and cancer.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

9.  A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.

Authors:  Anthony J Apicelli; Leonard B Maggi; Angela C Hirbe; Alexander P Miceli; Mary E Olanich; Crystal L Schulte-Winkeler; Anthony J Saporita; Michael Kuchenreuther; José Sanchez; Katherine Weilbaecher; Jason D Weber
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

10.  Selective inhibition of rDNA transcription by a small-molecule peptide that targets the interface between RNA polymerase I and Rrn3.

Authors:  Katrina Rothblum; Qiyue Hu; Yvonne Penrod; Lawrence I Rothblum
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.